Tamara Isakova

Research interests

Publications

• Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Kidney International · 2025 · 10.1016/j.kint.2024.11.013

• Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians

  JAMA Network Open · 2021 · 10.1001/jamanetworkopen.2021.37193

• KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)

  American Journal of Kidney Diseases · 2017 · 10.1053/j.ajkd.2017.07.019

• Longitudinal FGF23 Trajectories and Mortality in Patients with CKD

  Journal of the American Society of Nephrology · 2017 · 10.1681/asn.2017070772

• Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD

  American Journal of Kidney Diseases · 2017 · 10.1053/j.ajkd.2017.08.017

• Food Access, Chronic Kidney Disease, and Hypertension in the U.S.

  American Journal of Preventive Medicine · 2015 · 10.1016/j.amepre.2015.07.017

• Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

  Kidney International · 2015 · 10.1038/ki.2015.290

• KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD

  American Journal of Kidney Diseases · 2014 · https://doi.org/10.1053/j.ajkd.2014.01.416

• Fibroblast Growth Factor-23 and Cardiovascular Events in CKD

  Journal of the American Society of Nephrology · 2013 · 10.1681/asn.2013050465

• Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD

  Clinical Journal of the American Society of Nephrology · 2013 · 10.2215/cjn.09250912

• Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

  Kidney International · 2013 · 10.1038/ki.2013.3

• New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes

  PLoS Genetics · 2012 · 10.1371/journal.pgen.1002921

• Fibroblast Growth Factor 23 and Inflammation in CKD

  Clinical Journal of the American Society of Nephrology · 2012 · 10.2215/cjn.13281211

• Contaminated Cocaine and Antineutrophil Cytoplasmic Antibody-Associated Disease

  Clinical Journal of the American Society of Nephrology · 2011 · 10.2215/cjn.03440411

• Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

  Kidney International · 2011 · https://doi.org/10.1038/ki.2011.47

• Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

  JAMA · 2011 · https://doi.org/10.1001/jama.2011.826

• FGF23 induces left ventricular hypertrophy

  Journal of Clinical Investigation · 2011 · https://doi.org/10.1172/jci46122

• Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease

  Nephrology Dialysis Transplantation · 2010 · 10.1093/ndt/gfq419

• Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

  The Journal of Clinical Endocrinology & Metabolism · 2009 · 10.1210/jc.2009-1603

• Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

  Circulation · 2009 · https://doi.org/10.1161/circulationaha.108.844506

• Phosphorus Binders and Survival on Hemodialysis

  Journal of the American Society of Nephrology · 2008 · 10.1681/asn.2008060609

• Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD

  Journal of the American Society of Nephrology · 2008 · 10.1681/asn.2007060673

• Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

  New England Journal of Medicine · 2008 · 10.1056/nejmoa0706130

• Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?

  Kidney International · 2006 · 10.1038/sj.ki.5001788

• Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease

  Journal of the American Society of Nephrology · 2005 · 10.1681/asn.2005010052

Current projects

No projects listed.